Biotech · Private company
Neurim Pharmaceuticals Ltd.
Track this companyFree. Adds Neurim Pharmaceuticals Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Circadin 2/5/10 mgPhase 3 · Sleep DisordersClinicalTrials.gov · fetched Nov 12, 2026
- Piromelatine 20 mgPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PiromelatinePhase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's DiseasePHASE2_PHASE3 · TERMINATED · started Jun 15, 2022ClinicalTrials.gov NCT05267535 · fetched Nov 12, 2026
- Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)PHASE2 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02615002 · fetched Nov 12, 2026
- Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment DisabilitiesPHASE3 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01906866 · fetched Nov 12, 2026